Management of adverse effects of radiotherapy
50 results
1 - 50
Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus: Cochrane systematic review- Interventions for the treatment of oral cavity and oropharyngeal cancer: radiotherapy: Cochrane systematic review
- Pharmacological interventions for preventing dry mouth and salivary gland dysfunction following radiotherapy
- Surgery for limited‐stage small‐cell lung cancer
- Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma
- Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers
- Adjuvant chemotherapy for advanced endometrial cancer
- Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiation
- Radical multimodality therapy for malignant pleural mesothelioma
- Effectiveness of different treatment modalities for the management of adult‐onset granulosa cell tumours of the ovary (primary and recurrent)
- Radiotherapy for diffuse brainstem glioma in children and young adults
- External beam radiotherapy for unresectable hepatocellular carcinoma
- Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer
- Exenterative surgery for recurrent gynaecological malignancies
- Corticosteroids for adult patients with advanced cancer who have nausea and vomiting (not related to chemotherapy, radiotherapy, or surgery)
- Treatment of newly diagnosed glioblastoma in the elderly: a network meta‐analysis
- Adjuvant chemotherapy for resected early-stage non-small cell lung cancer: Cochrane systematic review
- Interventions for the management of dry mouth: non-pharmacological interventions: Cochrane systematic review
- Interventions for preventing osteoradionecrosis of the jaws in adults receiving head and neck radiotherapy
- Tumour bed boost radiotherapy for women after breast‐conserving surgery
- Adjuvant radiotherapy for stage I endometrial cancer
- Interventions for treating brain arteriovenous malformations in adults
- Thymic peptides for treatment of cancer patients: Cochrane systematic review
- Bisphosphonates for the relief of pain secondary to bone metastases
- Yoga in addition to standard care for patients with haematological malignancies
- Debulking hysterectomy followed by chemoradiotherapy versus chemoradiotherapy for FIGO stage (2019) IB3/II cervical cancer
- Alkylating agents for Waldenstrom's macroglobulinaemia
- Surgical removal versus retention for the management of asymptomatic disease‐free impacted wisdom teeth
- Therapeutic interventions for Burkitt lymphoma in children
- Therapeutic exercises for affecting post‐treatment swallowing in people treated for advanced‐stage head and neck cancers
- Axillary treatment for operable primary breast cancer: Cochrane systematic review
- Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support
- Lymphadenectomy for the management of endometrial cancer
- Biopsy versus resection for the management of low‐grade gliomas
- Sentinel node biopsy for diagnosis of lymph node involvement in endometrial cancer
- Pharmacological treatments for fatigue associated with palliative care: Cochrane systematic review
- Hormone replacement therapy for women previously treated for endometrial cancer
- Interventions for weight reduction in obesity to improve survival in women with endometrial cancer
- Lymphadenectomy or sentinel node biopsy for the management of endometrial cancer
- Exercise for women receiving adjuvant therapy for breast cancer
- Transfusion thresholds for guiding red blood cell transfusion